Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus
- PMID: 3261708
- PMCID: PMC1194195
- DOI: 10.1136/sti.64.3.176
Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus
Abstract
The ability of complement in human menstrual blood and cervical mucus to kill Trichomonas vaginalis was compared with that of complement in serum, and 95 fresh trichomonal isolates obtained from vaginal wash material were evaluated for susceptibility to complement immediately after isolation. Only serum and menstrual blood with haemolytic activity produced total cytolysis of T vaginalis. The cytolytic abilities of these fluids were totally inactivated by treatment with heat or edetic acid (EDTA), which confirms the role of complement in cytolysis. Most cervical mucus samples had no detectable trichomonal cytotoxic properties. The cytotoxic activity in the remaining samples was not due to complement, as it was heat stable. Fresh isolates of T vaginalis and subpopulations of fresh isolates differed in their susceptibility or resistance to complement mediated lysis in serum. Resistance to complement did not remain stable after trichomonads were grown in vitro.
Similar articles
-
Cytotoxic potential of cervical mucus on Trichomonas vaginalis to prevent upper genital tract infections.Saudi Med J. 2006 May;27(5):735-6. Saudi Med J. 2006. PMID: 16680275 No abstract available.
-
Killing of Trichomonas vaginalis by complement-mediated lysis is not associated with the presence of Trichomonas vaginalis virus.Int J Parasitol. 1993 Aug;23(5):675-80. doi: 10.1016/0020-7519(93)90177-z. Int J Parasitol. 1993. PMID: 8225773
-
Fewer Trichomonas vaginalis organisms in vaginas of infected women during menstruation.Genitourin Med. 1988 Feb;64(1):22-4. doi: 10.1136/sti.64.1.22. Genitourin Med. 1988. PMID: 3257936 Free PMC article.
-
Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis.Infect Immun. 1986 Sep;53(3):697-9. doi: 10.1128/iai.53.3.697-699.1986. Infect Immun. 1986. PMID: 3488964 Free PMC article.
-
Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection.J Clin Pathol. 1976 Feb;29(2):154-7. doi: 10.1136/jcp.29.2.154. J Clin Pathol. 1976. PMID: 58872 Free PMC article. Review.
Cited by
-
Trichomoniasis immunity and the involvement of the purinergic signaling.Biomed J. 2016 Aug;39(4):234-243. doi: 10.1016/j.bj.2016.06.007. Epub 2016 Sep 21. Biomed J. 2016. PMID: 27793265 Free PMC article. Review.
-
The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases.Genitourin Med. 1997 Aug;73(4):291-6. doi: 10.1136/sti.73.4.291. Genitourin Med. 1997. PMID: 9389953 Free PMC article.
-
Clinical and microbiological aspects of Trichomonas vaginalis.Clin Microbiol Rev. 1998 Apr;11(2):300-17. doi: 10.1128/CMR.11.2.300. Clin Microbiol Rev. 1998. PMID: 9564565 Free PMC article. Review.
-
Mouse endometrial stromal cells and progesterone inhibit the activation and regulate the differentiation and antibody secretion of mouse B cells.Int J Clin Exp Pathol. 2013 Dec 15;7(1):123-33. eCollection 2014. Int J Clin Exp Pathol. 2013. PMID: 24427332 Free PMC article.
-
Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions.Genitourin Med. 1990 Jun;66(3):193-9. doi: 10.1136/sti.66.3.193. Genitourin Med. 1990. PMID: 2370063 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical